MRL: Pembrolizumab/ Pembrolizumab concentrate for infusion, 25 mg/ml by 4 ml per code DC 021:2015: 33600000-6 Pharmaceutical products (DC 021:2015: 33652000-5 Anti-depressants and immunomodulators)
- 采购方
- prozorro_gov_ua
- 机构全称
- COMUNAL NECOMERCY PIDPRIEMSTVO " HERSONSKI REGIONALNALNAL ONCOLOGIC CENTER " has been established by the HERSONSKI RADY
- 国家/地区
- Ukraine
- 截止时间
- 2026-11-04
- 发布时间
- 2026-10-29
- 公告编号
- UA-2026-10-29-012819-a
- 预算/金额
- 27309.27
- 来源编号
- PROZORRO-UA-2026-10-29-012819-a
公告概况
Pembrolizumab: Classification according to the AATH: L01FF02, Classification according to the MRL: Pembrolizumab, Form of the drug: Concentrate for infusion, Dosage of the active substance: 25 mg/mL, Volume: 4 ml
查看完整公告
完整描述、联系方式与采购文件需登录后查看。